Nicholas Campbell is named as a lobbyist on federal disclosure filings for 6 clients through Capitalhill Advisory. The most recent filing naming them posted in April 2015. Issues reported include Copyright/Patent/Trademark, Health Issues, Pharmacy and Trade (domestic/foreign).
| Client | Registrant | Latest | Issues |
|---|---|---|---|
| MERCK SHARP & DOHME | CAPITALHILL ADVISORY | Q1 2015 | Economics/Economic Development, Health Issues, Pharmacy |
| BRISTOL-MYERS SQUIBB AUSTRALIA PTY LTD | CAPITALHILL ADVISORY | Q1 2015 | Economics/Economic Development, Health Issues, Pharmacy |
| SANOFI-AVENTIS AUSTRALIA PTY LTD | CAPITALHILL ADVISORY | Q1 2015 | Economics/Economic Development, Health Issues, Pharmacy |
| PFIZER AUSTRALIA PTY LTD | CAPITALHILL ADVISORY | Q1 2015 | Economics/Economic Development, Health Issues, Pharmacy |
| NOVARTIS PHARMACEUTICALS PTY LTD ( AUSTRALIA) | CAPITALHILL ADVISORY | Q1 2015 | Economics/Economic Development, Health Issues, Pharmacy |
| ASTRAZENECA PTY LIMITED | CAPITALHILL ADVISORY | Q1 2015 | Economics/Economic Development, Health Issues, Pharmacy |
| Year | Clients | Registrants |
|---|---|---|
| 2015 | 6 | 1 |
| 2014 | 6 | 1 |
Pay is not disclosed for individual lobbyists. Filings do not confirm that records with the same name are one person, so this page may combine people who share the name Nicholas Campbell. See the Capitol Clarity rankings and method.